Fair value (multi-method)
Four independent methods triangulate what BMY is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$195.03
Method range
$17.02 – $195.03
median $90.92
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $195.03 | +220.98% |
| Exit multiple | $118.60 | +95.19% |
| Analyst target | $63.25 | +4.10% |
| Graham number | $17.02 | -71.99% |
- Forward DCF$195.03
- Exit multiple$118.60
- Analyst target$63.25
- Graham number$17.02
Stock price
$60.76
FCF / share (TTM)
$0.37
3Y FCF CAGR
-1.9%
Fair value @ hist. growth
$7.83
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
23.1%
per year over your projection horizon
Margin of safety -676.0% vs hist-growth DCF
Historical 3Y CAGR
-1.9%
Your model implies
23.1%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -2% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | 22.7% | 21.0% | 19.0% | 16.5% | 13.4% |
| 5.0% | 22.7% | 21.0% | 19.0% | 16.5% | 13.4% |
| 5.8% | 26.1% | 24.7% | 23.1% | 21.3% | 19.1% |
| 6.8% | 29.6% | 28.4% | 27.2% | 25.8% | 24.2% |
| 7.8% | 32.7% | 31.7% | 30.7% | 29.5% | 28.3% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.08
Low vs growth
Net debt
$36.9B
Total debt − cash
Beta
0.24
Vs market benchmark
Frequently asked questions
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.08% TTM
- Dividend Profile4.13% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.